Cannabinit

Cannabinit is a Poland-linked medical cannabis biotechnology company formed with support from the iCAN Israel-Cannabis incubator. The company was launched around 2018 to commercialize a plant-cell-based production technology designed to generate high-quality cannabis plant cells in vitro rather than through conventional cultivation. Its core value proposition appears to be controlled, facility-light production of cannabinoid-containing plant biomass for medical cannabis and related applications. Public information on a clinical drug pipeline, named therapeutic programs, financing history, and current operating scale is very limited, suggesting it remains an early-stage private platform company rather than a clinical-stage therapeutics developer.